Skip to Content

Logo 202 Logo 202 (Methylphenidate hydrochloride extended-release 40 mg)

Pill imprint Logo 202 Logo 202 has been identified as Methylphenidate hydrochloride extended-release 40 mg.

Methylphenidate is used in the treatment of adhd; narcolepsy; obesity; fatigue; depression (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Methylphenidate hydrochloride extended-release 40 mg Logo 202 Logo 202
Methylphenidate hydrochloride extended-release 40 mg Logo 202 Logo 202
Methylphenidate hydrochloride extended-release
Imprint:
Logo 202 Logo 202
Strength:
40 mg
Color:
White / Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Actavis South Atlantic LLC

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide